Combination of inositol and serotonin reuptake inhibitors in the treatment of depression

Biological Psychiatry

Volumn 45, Issue 3, 1999, Pages 270-273

  Levine, Joseph ^a   Mishori, Alex ^b   Susnosky, Michael ^c   Martin, Michael ^c   Belmaker, Robert H ^a  

^a MENTAL HEALTH CENTER   (Israel)

^b Barzilai Hospital   (Israel)

^c ABARBANEL MENTAL HEALTH CENTER   (Israel)

Author keywords

Combined treatment; Inositol; Major depression; Serotonin selective reuptake inhibitors

Indexed keywords

FLUOXETINE; FLUVOXAMINE; INOSITOL; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG MIXTURE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN SYNDROME;

ADULT; AGED; ANALYSIS OF VARIANCE; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INOSITOL; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0033083148     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00145-0     Document Type: Article

References (25)

1. Abrams R. Drugs in combination with ECT. Greenblatt M. Drugs in Combination with Other Therapies. 1975;157-164 Grun & Stratton, 1975, New York.
2. Benjamin J., Levine J., Fux M., Aviv A., Levy D., Belmaker R.H. Double blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry. 152:1995;1084-1086.
3. Berman R.M., Darnell A.M., Miller H.L., Anand A., Charney D.S. Effect of pinadol in hastening response to fluoxetine in the treatment of major depression A double-blind, placebo controlled trial . Am J Psychiatry. 154:1997;37-43.
4. Biederman H.J., Lerner Y., Belmaker R.H. Combination of lithium carbonate and haloperidol in schizoaffective disorder A controlled study . Arch Gen Psychiatry. 36:1979;327-333.
5. Blier P., Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol. 15:1995;217-222.
6. Coppen A., Whybrow P.C., Noguera R., Maggs R., Prange A.J. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry. 26:1972;234-241.
7. de Montigny C., Grunberg P., Mayer A., Deschenes J.P. Lithium induces a rapid relief of depression in tricyclic antidepressants drug non responders. Br J Psychiatry. 138:1981;252.
8. de Montigny C., Cournoyer G., Morissette R., Langlois R., Caille G. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Arch Gen Psychiatry. 40:1983;1327-1334.
9. de Montigny C., Elie R., Caille G. Rapid response to the addition of lithium in iprindole-resistant unipolar depression A pilot study . Am J Psychiatry. 142:1985;220-223.
10. Ebert D., Jaspert A., Murata H., Kaschka W.P. Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients. Psychopharmacology (Berl). 118:1995;223-225.
11. Feighner J.P., King L.J., Schuckit M.A., Croughan J., Briscoe W. Hormonal potentiation of imipramine and ECT in primary depression. Am J Psychiatry. 128:1972;1230-1238.
12. Fux M., Levine J., Aviv A., Belmaker R.H. Inositol treatment of obsessive compulsive disorder. Am J Psychiatry. 153:1996;1219-1221.
13. Klein E., Bental E., Lerer B., Belmaker R.H. Carbamazepine and haloperidol vs placebo and haloperidol in excited psychosis. Arch Gen Psychiatry. 41:1984;165-170.
14. Levine J., Goldberger I., Rapaport A., Schwartz M., Schields C., Elizur A., et al. CSF inositol levels in schizophrenia are unchanged and inositol is not therapeutic in anergic schizophrenia. Eur Neuropsychopharmacol. 4:1994;487-490.
15. Levine J., Barak Y., Gonzalves M., Szor H., Elizur A., Kofman O., et al. Double blind controlled trial of inositol treatment of depression. Am J Psychiatry. 152:1995;792-794.
16. Lingaerde O., Edlud A.H., Gormsen C.A., Gottfries C.G., Haugstad A., Hermann L.L., et al. The effect of lithium carbonate with tricyclic antidepressant in endogenous depression. Acta Psychiatr Scand. 50:1974;2332-2342.
17. Nelson C.J. Combined treatment strategies in psychiatry. J Clin Psychiatry. 54:1993;42-49.
18. Nick J., Wante J.P., Des Lauriers A., Moinet A., Monfort J. L'association clomipramine-lithium Essai control . Encephale. 2:1976;5-12.
19. Sahal B., Piel E., Mencz L., Kremer I., Klein E. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of depression - A double blind controlled study. Biol Psychiatry. 40:1996;1181-1183.
20. Taylor D. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination Interaction and therapeutic uses . Br J Psychiatry. 167:1995;575-580.
21. Wheatley D. Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry. 26:1972;229-233.
22. White K., Razari J., Simpson G., Rebal R., Bruce Soalne R., O'Leary J., et al. Combined MAOI-tricyclic antidepressant treatment A controlled trial . Psychopharmacol Bull. 18:1982;180-181.
23. Wu J.C., Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse Review and hypothesis . Am J Psychiatry. 147:1990;14.
24. Young J.P.R., Lader M.H., Hughes W.C. Controlled trial of trimipramine, mono-amine oxidase inhibitors and combined treatment in depressed outpatients. Br Med J. 4:1979;1315-1317.
25. Zohar J, Belmaker RH, editors, (1987): Treating Resistant Depression. New York: Spectrum Press.